| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2800365302010 | 36530201 | IREMOFAR F.C.TAB 25MG BTX30 | 0.90 | 0.94 | 1.30 |
| 05/2018 | 2800365304021 | 36530402 | IREMOFAR ORAL.SOL 10MG/5ML FLX150ML | 0.98 | 01.03 | 1.42 |
For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria.
Hydroxyzine competes with histamine for binding at H<sub>1</sub>-receptor sites on the effector cell surface, resulting in suppression of histaminic edema, flare, and pruritus. The sedative properties of hydroxyzine occur at the subcortical level of the CNS. Secondary to its central anticholinergic actions, hydroxyzine may be effective as an antiemetic.
Oral, rat LD<sub>50</sub>: 950 mg/kg. Symptoms of overexposure include hypersedation.
Rapidly absorbed from the gastrointestinal tract
20 to 25 hours